A detailed history of Israel Englander (Millennium Management LLC) transactions in Verona Pharma PLC stock. As of the latest transaction made, Millennium Management LLC holds 160,006 shares of VRNA stock, worth $7.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160,006
Previous 527,640 69.68%
Holding current value
$7.25 Million
Previous $7.63 Million 39.66%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.46 - $30.16 $5.68 Million - $11.1 Million
-367,634 Reduced 69.68%
160,006 $4.6 Million
Q2 2024

Aug 14, 2024

BUY
$11.48 - $17.02 $270,549 - $401,110
23,567 Added 4.68%
527,640 $7.63 Million
Q1 2024

May 15, 2024

BUY
$15.3 - $20.24 $1.85 Million - $2.44 Million
120,722 Added 31.49%
504,073 $8.11 Million
Q4 2023

Feb 14, 2024

SELL
$11.94 - $20.47 $1.79 Million - $3.07 Million
-150,133 Reduced 28.14%
383,351 $7.62 Million
Q2 2023

Aug 14, 2023

SELL
$19.41 - $23.43 $335,365 - $404,823
-17,278 Reduced 3.14%
533,484 $11.3 Million
Q1 2023

May 15, 2023

BUY
$18.06 - $25.27 $4.27 Million - $5.98 Million
236,709 Added 75.37%
550,762 $11.1 Million
Q4 2022

Feb 14, 2023

BUY
$9.84 - $26.13 $2.31 Million - $6.13 Million
234,713 Added 295.83%
314,053 $8.21 Million
Q3 2022

Nov 14, 2022

BUY
$4.14 - $13.59 $328,467 - $1.08 Million
79,340 New
79,340 $811,000
Q2 2022

Aug 15, 2022

SELL
$3.55 - $5.06 $95,136 - $135,602
-26,799 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.82 - $6.98 $52,200 - $75,593
10,830 Added 67.82%
26,799 $134,000
Q4 2021

Feb 14, 2022

BUY
$3.91 - $7.08 $4,625 - $8,375
1,183 Added 8.0%
15,969 $107,000
Q3 2021

Nov 15, 2021

BUY
$5.29 - $6.35 $78,217 - $93,891
14,786 New
14,786 $81,000
Q4 2020

Feb 16, 2021

SELL
$5.51 - $8.11 $60,290 - $88,739
-10,942 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.45 - $10.2 $48,691 - $111,608
10,942 New
10,942 $68,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.76B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.